Related Experiment Video
Updated: Sep 4, 2025

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
Epigenetic and transcriptome responsiveness to ER modulation by tissue selective estrogen complexes in breast
Terri L Messier1,2, Joseph R Boyd1, Jonathan A R Gordon1,2
1Department of Biochemistry, University of Vermont Larner College of Medicine, Burlington, VT, United States of America.
Abstract:
Selective estrogen receptor modulators (SERMs), including the SERM/SERD bazedoxifene (BZA), are used to treat postmenopausal osteoporosis and may reduce breast cancer (BCa) risk. One of the most persistent unresolved questions regarding menopausal hormone therapy is compromised control of proliferation and phenotype because of short- or long-term administration of mixed-function estrogen receptor (ER) ligands. To gain insight into epigenetic effectors of the transcriptomes of hormone and BZA-treated BCa cells, we evaluated a panel of histone modifications. The impact of short-term hormone treatment and BZA on gene expression and genome-wide epigenetic profiles was examined in ERαneg mammary epithelial cells (MCF10A) and ERα+ luminal breast cancer cells (MCF7). We tested individual components and combinations of 17β-estradiol (E2), estrogen compounds (EC10) and BZA. RNA-seq for gene expression and ChIP-seq for active (H3K4me3, H3K4ac, H3K27ac) and repressive (H3K27me3) histone modifications were performed. Our results show that the combination of BZA with E2 or EC10 reduces estrogen-mediated patterns of histone modifications and gene expression in MCF-7ERα+ cells. In contrast, BZA has minimal effects on these parameters in MCF10A mammary epithelial cells. BZA-induced changes in histone modifications in MCF7 cells are characterized by altered H3K4ac patterns, with changes at distal enhancers of ERα-target genes and at promoters of non-ERα bound proliferation-related genes. Notably, the ERα target gene GREB1 is the most sensitive to BZA treatment. Our findings provide direct mechanistic-based evidence that BZA induces epigenetic changes in E2 and EC10 mediated control of ERα regulatory programs to target distinctive proliferation gene pathways that restrain the potential for breast cancer development.
Insights
Selective estrogen receptor modulators like bazedoxifene (BZA) can reduce breast cancer risk by altering epigenetic modifications in estrogen receptor-positive cells. BZA impacts gene expression and histone modifications, potentially restraining breast cancer development.
Area of Science:
- Endocrinology
- Epigenetics
- Oncology
Background:
- Selective estrogen receptor modulators (SERMs) are used for osteoporosis and may lower breast cancer (BCa) risk.
- Estrogen receptor (ER) ligand administration can compromise cellular proliferation control.
- Epigenetic mechanisms underlying hormone and SERM effects on BCa cells require elucidation.
Purpose of the Study:
- To investigate the epigenetic impact of bazedoxifene (BZA) and estrogen compounds (E2, EC10) on gene expression and histone modifications in breast cancer cells.
- To compare BZA's effects in ERα-positive (MCF7) and ERα-negative (MCF10A) cells.
Main Methods:
- RNA sequencing (RNA-seq) for gene expression analysis.
- Chromatin immunoprecipitation sequencing (ChIP-seq) to assess active (H3K4me3, H3K4ac, H3K27ac) and repressive (H3K27me3) histone modifications.
- Treatment of MCF7 and MCF10A cells with 17β-estradiol (E2), estrogen compounds (EC10), and BZA, individually and in combination.
Main Results:
- BZA combined with E2 or EC10 reduced estrogen-mediated histone modifications and gene expression in MCF7 ERα+ cells.
- BZA had minimal effects on histone modifications and gene expression in MCF10A cells.
- BZA altered H3K4ac patterns in MCF7 cells, affecting ERα target genes like GREB1 and proliferation-related genes.
Conclusions:
- Bazedoxifene induces epigenetic changes that modulate estrogen receptor regulatory programs.
- These BZA-induced epigenetic alterations target proliferation pathways, suggesting a mechanism for restraining breast cancer development.
- BZA's effects are specific to ERα-positive cells, highlighting its potential in breast cancer risk reduction.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Mitogens and the Cell Cycle
Regulation of the Unfolded Protein Response
Master Transcription Regulators

